Stephen A. Trowbridge
Executive VP & CFOMr. Stephen A. Trowbridge, also known as Steve, has been Executive Vice President and Chief Financial Officer at AngioDynamics, Inc. since February 5, 2020. He served as General Counsel at AngioDynamics, Inc. since June 2010 until January 31, 2021 and served as its Senior Vice President since August 2013 until February 05, 2020 and served as its Interim Chief Financial Officer October 23, 2019 until February 05, 2020 and also served as its Assistant Secretary. Mr. Trowbridge manages AngioDynamics’ legal matters, including corporate governance, mergers and acquisitions, finance, securities regulation, litigation, regulatory matters, intellectual property and compliance. Mr. Trowbridge also oversees AngioDynamics’s clinical affairs, medical affairs and healthcare economics departments. He joined AngioDynamics, Inc. as corporate counsel in June 2008 and was its Vice President since June 2010. Prior to AngioDynamics, Mr. Trowbridge served as Corporate Counsel at Philips Healthcare and Intermagnetics General Corporation. Mr. Trowbridge began his career with Cadwalader, Wickersham & Taft LLP in the firm’s Mergers and Acquisitions and Securities Group. Mr. Trowbridge received a Bachelor of Science in Science and Technology Studies from Rensselaer Polytechnic Institute, a Juris Doctor from the University of Pennsylvania Law School, and a Master of Business Administration from Duke University’s Fuqua School of Business.
Positions
- Company NameAngioDynamics, Inc.Stock CodeANGOPositionExecutive VP & CFOColleagues
- EOEileen O'Shea AuenIndependent Non-Executive Chairman of the Board
- LTLawrence T. WeissSenior VP, Chief Legal Officer & Corporate Secretary
- WGWarren G. NighanSenior Vice President of Regulatory Affairs, Quality & Global Supply Chain
- LPLaura PiccininiSenior VP and GM of Cardiovascular & International
- EHEric HonrothPresident, CEO & Director
- WEWesley E. JohnsonIndependent Director
- JSJan Stern ReedIndependent Director
- KAKaren A. LicitraIndependent Director
